We are live on
!
Find out more
Moleculin Biotech
MBRX
MBRX
20 hedge funds and large institutions have $348K invested in Moleculin Biotech in 2026 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.24% less ownership
Funds ownership: 3.09% → 2.85% (-0.24%)
Holders
20
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$248K | |
| 2 | +$56.9K | |
| 3 | +$45.5K | |
| 4 |
Rockefeller Capital Management
New York
|
+$13.9K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.46K |
Top Sellers
| 1 | -$110K | |
| 2 | -$74.6K | |
| 3 | -$8.12K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$119 |
| 5 |
BlackRock
New York
|
-$13 |
